On behalf of the team at Prescient Surgical, I’d like to welcome those attending ASCRS to the dynamic City of Angels! 4 years after launching Prescient Surgical out of the Stanford Biodesign Program in 2012, I’m excited to announce the launch of this blog and share what we’ve learned about preventing surgical site infection. SSI remains one of the top issues in colorectal surgery, and I invite you to join in on the thought-provoking, science-based conversation we intend to promote on this blog.
I’ve personally enjoyed the privilege of attending ASCRS in the past, mostly in engineering and marketing roles at Ethicon and Covidien, where I learned how our technologies enable the ever-evolving clinical approaches developed by this community. And frankly, we wouldn’t be able to do any of it without your help. Prescient Surgical has benefited greatly from the generous support of the clinicians attending this meeting. In fact, some of you might recall in 2012 a certain “World’s Longest Paper-based Survey,” administered by myself and my co-founders, designed to get feedback on the next-generation wound retraction and protection products we were developing at the time.
We’ve come a long way since then. We’ve grown the company significantly, expect to finish enrollment in a large multi-center U.S. clinical trial this spring, and have worked to expand and update our product portfolio in view of responses from regulatory agencies. Founded around a core of engineers, scientists, and physicians, we remain committed to a science-forward approach. I’m proud of all that we’ve accomplished, and I look forward to reconnecting with the many colleagues and friends we’ve developed along the way this week in LA.